TP53 and breast cancer: Moreover, a study reported that about 38% of aromatase inhibitor-resistant BC carry p53 mutations and they are associated with high-grade histology and high proliferation rates, corroborating the correlation between p53 mutation, lipid metabolism and tumor architecture [71].